Hellman Jordan Management Company’s Gilead Sciences GILD Stock Holding History

Hellman Jordan Management Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,228	Closed	-$829K	–	49
2017 Q3	$829K	Sell	10,228 -1,632	-14%	-$125K	1.8%	19
2017 Q2	$839K	Buy	+11,860	New	+$789K	1.8%	20
2016 Q4	$1.23M	Sell	17,160 -9,707	-36%	-$722K	1.68%	21
2016 Q3	$1.98M	Buy	26,867 +4,100	+18%	+$333K	2%	5
2016 Q2	$1.9M	Buy	22,767 +4,374	+24%	+$388K	3.83%	6
2016 Q1	$1.69M	Sell	18,393 -65,215	-78%	-$5.88M	4.3%	5
2015 Q4	$8.46M	Sell	83,608 -57,128	-41%	-$5.94M	2.04%	29
2015 Q3	$13.8M	Buy	140,736 +47,290	+51%	+$5.25M	3.42%	8
2015 Q2	$10.9M	Buy	+93,446	New	+$10.2M	2.5%	18

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hellman Jordan Management Company's GILD Position: Q4 2017 in Review

Hellman Jordan Management Company sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 10,228 shares — an estimated $829K sold.

Hellman Jordan Management Company first reported a position in GILD in Q2 2015 and held it in 9 quarters. The position peaked at $13.8M in Q3 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

Hellman Jordan Management Company reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
Hellman Jordan Management Company sold 10,228 Gilead Sciences shares in Q4 2017, an estimated $829K.
Hellman Jordan Management Company first reported a position in Gilead Sciences in Q2 2015 and held it in 9 quarters.
Hellman Jordan Management Company's Gilead Sciences position peaked at $13.8M in Q3 2015.
1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Hellman Jordan Management Company's 13F filing for Q4 2017, filed 1 Mar 2018.